Last updated: 2026-09-05 19:46:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
CryoPort, Inc. (CYRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $15.81, with a market capitalization of $799.24M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.61 to $17.20. This page covers its latest market performance, valuation, price trends and company information.
$799.24M | |
$15.86 | |
$86.30 | |
$1.03 | |
$15.86 | |
243.71K | |
-- | |
-- | |
$17.20 | |
$7.61 | |
-- | |
-- |
CryoPort, Inc. (CYRX) last closed at $15.86 as of 2026-09-04 23:31:00, unchanged from the previous close of $15.86.
During the latest regular trading session, CYRX traded between $1.03 and $86.30, with a volume of 243.71K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, CryoPort, Inc. (CYRX) moved from $15.92 to $15.81, representing a decline of 0.67% ($0.11).
The stock traded between $15.62 and $16.36 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 413.14 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 85.5%
CYRX is currently trading at $15.81, placing it 85.5% of the way from its 52-week low of $7.61 to its 52-week high of $17.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 738 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CryoPort, Inc. (CYRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.